Wegovy® resulted in a BMI reduction of 10% or more in almost 80% of children with obesity aged 6 to under 12, compared to 0% with placebo in STEP Young trial, published in The New England Journal of Medicine
News provided by Childhood obesity was estimated to affect around 177 million children and teens ages 5 to 19 globally in 20252 PLAINSBORO, N.J. and BAGSVÆRD, Denmark, /PRNewswire/ -- Today, Novo Nordisk shared primary results from the phase 3 STEP Young trial evaluating the safety and efficacy of investigational once-weekly…